Related Experiment Video
Updated: May 1, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
[Anti-inflammatory effects of apoprotein AI are mediated via modulating macrophage polarity]
Quanzhong Li1, Zhenli Zhai1, Weihong Ma1
1Department of Cardiology, Affiliated Hospital of Guilin Medical College, Guilin 541001, China.
Objective:
To explore the anti-inflammatory mechanisms of high density lipoprotein (HDL) by observing the effects of apoprotein (apo)AI, a major protein component of HDL, on the inflammatory macrophage cell polarity.
Methods:
Cultured mice marrow-derived macrophages were stimulated with lipopolysaccharide and interferon after 10 µg/ml of apoAI were added to the macrophages for 24 hours. The expression of membrane molecules CD16/32, CD206 were detected by fluorescence activated cell sorting (FACS). ELISA was used to detect the secretion of IL-10 and IL-12. Real-time quantitative PCR was used to detect the mRNA expression of TLR4, MyD88 and IRF5.
Results:
Compared to macrophages stimulated by interferon and lipopolysaccharide but without pretreatment with apoAI, pre-incubation with apoAI significantly downregulated the expression of CD16/32 (91.17% ± 1.99% vs.50.47% ± 1.02%, P < 0.05), IL-12 [(747.27 ± 3.74)pg/ml vs. (73.80 ± 4.56)pg/ml, P < 0.05], upregulated the expression of CD206(0.33% ± 0.12% vs. 3.00% ± 0.36%, P < 0.05), IL -10 expression [(23.56 ± 4.30) pg/ml vs.(32.91 ± 2.47) pg/ml, P < 0.05], and reduced the mRNA expression of TLR4 (1.000 ± 0.025 vs.0.708 ± 0.003, P < 0.05) , MyD88 (1.591 ± 0.005 vs. 1.341 ± 0.005, P < 0.05) , IRF5 (0.954 ± 0.005 vs. 0.463 ± 0.003, P < 0.05) .
Conclusion:
ApoAI enhances the switch of inflammatory macrophages to anti-inflammatory macrophages possibly through inhibiting TLR4-MyD88-IRF5 pathway.
Insights
Apoprotein AI (apoAI) from high-density lipoprotein (HDL) shifts inflammatory macrophages to an anti-inflammatory state. This occurs by inhibiting the Toll-like receptor 4 (TLR4)-MyD88-IRF5 pathway, reducing pro-inflammatory markers.
Area of Science:
- Immunology
- Molecular Biology
- Cardiovascular Research
Background:
- High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport and possesses anti-inflammatory properties.
- Apolipoprotein AI (apoAI) is the primary protein component of HDL, mediating many of its biological functions.
- Macrophage polarization is critical in regulating inflammatory responses, with a shift from pro-inflammatory (M1) to anti-inflammatory (M2) phenotypes being therapeutically relevant.
Purpose of the Study:
- To investigate the anti-inflammatory mechanisms of apoAI, a key component of HDL.
- To determine the effect of apoAI on the inflammatory macrophage cell polarity.
- To elucidate the molecular pathways involved in apoAI-mediated macrophage polarization.
Main Methods:
- Murine bone marrow-derived macrophages were cultured and stimulated with lipopolysaccharide (LPS) and interferon (IFN).
- Macrophages were pre-incubated with 10 µg/ml of apoAI for 24 hours prior to stimulation.
- Flow cytometry (FACS) was used to assess surface marker expression (CD16/32, CD206).
- Enzyme-linked immunosorbent assay (ELISA) measured cytokine secretion (IL-10, IL-12).
- Quantitative real-time PCR (qRT-PCR) analyzed mRNA expression of key pathway components (TLR4, MyD88, IRF5).
Main Results:
- ApoAI pre-treatment significantly downregulated the expression of pro-inflammatory markers CD16/32 and IL-12.
- ApoAI significantly upregulated the expression of anti-inflammatory marker CD206 and the anti-inflammatory cytokine IL-10.
- ApoAI significantly reduced the mRNA expression of Toll-like receptor 4 (TLR4), Myeloid differentiation primary response 88 (MyD88), and Interferon regulatory factor 5 (IRF5).
Conclusions:
- ApoAI promotes the polarization of inflammatory macrophages towards an anti-inflammatory phenotype.
- The mechanism involves the inhibition of the TLR4-MyD88-IRF5 signaling pathway.
- These findings highlight apoAI as a potential therapeutic agent for inflammatory diseases.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Inflammation
Chronic Inflammation: Introduction

